期刊文献+

冬凌草甲素片对醋酸诱导的小鼠溃疡性结肠炎的治疗作用(英文) 被引量:6

Therapeutic Effect of Oridonin Tablet on Acetic Acid-induced Ulcerative Colitis in Mice
原文传递
导出
摘要 目的考察冬凌草甲素片口服给药对醋酸诱导的小鼠溃疡性结肠炎的治疗作用。方法醋酸诱导的溃疡性结肠炎小鼠分别给予不同剂量的冬凌草甲素片灌胃给药,给药7 d后,考察冬凌草甲素片对溃疡性结肠炎小鼠病变活动(体质量、便潜血及粪便性状)的影响,以及对结肠病理组织学变化,结肠髓过氧化物酶活性及胸腺和脾脏指数的影响。结果冬凌草甲素片口服给药可剂量依赖性的降低结肠炎小鼠的病变活动、减轻结肠炎症、降低髓过氧化物酶活性,改善免疫器官脏器指数,以冬凌草甲素片高剂量给药组的作用更为显著。结论高剂量冬凌草甲素片口服给药对醋酸诱导的小鼠溃疡性结肠炎具有治疗作用,其机制可能与冬凌草甲素的抗炎和免疫调节作用有关。 OBJECTIVE To investigate the therapeutic effect of Oridonin tablet on acetic acid-induced ulcerative colitis in mice.METHODS Oridonin tablets at different dosages were administered orally to acetic acid-induced colitis mice.After 7 days of treatment,the effects of Oridonin tablet on disease activity(i.e.body weight,stool blood,and stool consistency),colonic macroscopic and histological score,myleoperoxidase activity,and thymic and splenic indexes were evaluated in acetic acid-induced ulcerative colitis in mice.RESULTS Oridonin tablet treatment dose-dependently reduced the disease activity,attenuated colonic inflammation and myleoperoxidase activity,and improved the thymic and splenic indexes in acetic acid-induced ulcerative colitis in mice,especially in high dose of Oridonin tablet treated group.CONCLUSION High dose of Oridonin tablet treatment shows therapeutic effect on acetic acid-induced ulcerative colitis in mice,the underlying mechanism may have close correlation with its anti-inflammatory and immune regulatory effects.
出处 《中国现代应用药学》 CAS CSCD 2012年第9期781-785,共5页 Chinese Journal of Modern Applied Pharmacy
关键词 冬凌草甲素 溃疡性结肠炎 治疗作用 小鼠 oridonin ulcerative colitis therapeutic effect mice
  • 相关文献

参考文献18

  • 1MARSHALL J K. Are there epidemiological differences between crohn's disease and ulcerative colitis? [J]. Inflammatory Bowel Diseases, 2008, 14(2): S1-S39.
  • 2JAGTAP A G, SHIRKE S S, PHADKE A S. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases [J]. Ethnopharmacol, 2004, 90(2/3): 195-204.
  • 3LAKATOS P L, LAKATOS L. Ulcerative proctitis: a review of pharmacotherapy and management [J]. Expert Opin Pharmacother, 2008, 9(5): 741-749.
  • 4LIMDI J K, BUTCHER R O. Complementary and alternative medicine use in inflammatory bowel disease [J]. Inflamm Bowel Dis, 2011, 17(8): E86-88.
  • 5HILSDEN R J, VERHOEF M J, RASMUSSEN H, et al. Use of complementary and alternative medicine by patients with inflammatory bowel disease [J]. Inflamm Bowel Dis, 2011, 17(2): 655-662.
  • 6CHEN Y C, CHEN F P, CHEN T J, et al. Patterns of traditional Chinese medicine use in patients with inflammatory bowel disease: a population study in Taiwan [J]. Hepatogastroenterology, 2008, 55(82/83): 467-470.
  • 7SONG F J, WU S J, LIANG J J. Study on antibacterial activity about isodon rubescens from badong [J]. 中南民族大学学报,2004,23(4):9-11.
  • 8LI C Y, WANG E Q, CHENG Y, et al. Oridonin: an acftive diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics [J]. Int J Bioehem Cell Biol, 2011;43(5): 701-704.
  • 9IKEZOE T, YANG Y, BANDOBASHI K, et al. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways [J]. Mol Cancer Ther, 2005, 4(4): 578-586.
  • 10LEUNG C H, GRILL S P, LAM W, et al. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens [J]. Mol Pharmacol, 2005, 68(2): 286-297.

同被引文献49

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部